If RC220 in combo with doxorubicin enhances cancer killing effects without increasing cardiotoxicity but also without reducing it, meaning it’s not inherently cardio protective, wouldn't it still be a desirable and marketable drug?
RAC Price at posting:
$1.43 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)